Search Results - "Velankar, M"

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib by Chauhan, Dharminder, Catley, Laurence, Li, Guilan, Podar, Klaus, Hideshima, Teru, Velankar, Mugdha, Mitsiades, Constantine, Mitsiades, Nicolas, Yasui, Hiroshi, Letai, Anthony, Ovaa, Huib, Berkers, Celia, Nicholson, Benjamin, Chao, Ta-Hsiang, Neuteboom, Saskia T.C., Richardson, Paul, Palladino, Michael A., Anderson, Kenneth C.

“…Bortezomib therapy has proven successful for the treatment of relapsed and/or refractory multiple myeloma (MM); however, prolonged treatment is associated with…”
Get full text

A novel Bcl-2/Bcl-XL/Bcl-W inhibitor ABT-737 as therapy in multiple myeloma by CHAUHAN, D, VELANKAR, M, ANDERSON, K. C, BRAHMANDAM, M, HIDESHIMA, T, PODAR, K, RICHARDSON, P, SCHLOSSMAN, R, GHOBRIAL, I, RAJE, N, MUNSHI, N

“…Bcl-2 or Bcl-X(L) confers resistance to chemotherapy in multiple myeloma (MM). Here we characterized the effects of ABT-737, a potent small-molecule inhibitor…”
Get full text

Auer rod‐like inclusions in monoclonal B‐cell lymphoproliferative disorder: A potential diagnostic pitfall by Sojitra, Payal, Nam, Moon‐woo, Omman, Reeba, Velankar, Milind M

Get full text

“Popcorn cells” in intraoperative touch imprints of nodular lymphocyte‐predominant Hodgkin lymphoma by Aragao, Alessa, Kilic, Irem, Velankar, Milind M., Pambuccian, Stefan E.

Get full text

Bone marrow imprints of crystal‐storing histiocytosis by Kilic, Irem, Picken, Maria M., Velankar, Milind M., Pambuccian, Stefan E.

Get full text

Indolent T-lymphoblastic proliferation : Report of a case with a 16-year course without cytotoxic therapy by VELANKAR, M. M, NATHWANI, B. N, SCHLUTZ, M. J, BAIN, L. A, ARBER, D. A, SLOVAK, M. L, WEISS, L. M

“…T-lymphoblastic lymphoma is a high-grade malignant lymphoma. Clinically indolent T-lymphoblastic proliferations have not been described. We present a case…”
Get full text

Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression by Sojitra, Payal, Gandhi, Pranav, Fitting, Priscilla, Kini, Ameet R, Alkan, Serhan, Velankar, Milind M, Venkataraman, Girish

“…To examine the utility of CD11c expression on monocytes in normal controls and patients with chronic myelomonocytic leukemia (CMML) (n = 23) with flow…”
Get full text

Pure erythroid leukaemia diagnosed on liver biopsy with concurrent haemophagocytic lymphohistiocytosis by Roquiz, Woodlyne, Kini, Ameet R., Velankar, Milind M.

Get full text

Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML) by Thakral, Beenu, Higa, Bryce, Venkataraman, Girish, Velankar, Milind M.

Get full text

Revisiting Howell-Jolly Body-Like Cytoplasmic Inclusions in Neutrophils: A Report of Two Cases and Confirmation of Nuclear Origin by Omman, Reeba, Kwong, Christina, Shepherd, Daniel, Molnar, Jo A, Velankar, Milind M, Mirza, Kamran M

“…Howell-Jolly body-like inclusions in neutrophils have been reported in a handful of reports; however, their nuclear origin has never been confirmed to date. We…”
Get full text

Ocular involvement by T-cell post-transplant lymphoproliferative disorder of cutaneous origin by Velankar, Milind M., Kini, Ameet R.

Get full text

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma by ZUCKERMAN, E, ZUCKERMAN, T, LEVINE, A. M, DOUER, D, GUTEKUNST, K, MIZOKAMI, M, QIAN, D. G, VELANKAR, M, NATHWANI, B. N, FONG, T.-L

“…Several studies from Europe have reported a high prevalence (9% to 32%) of chronic hepatitis C virus (HCV) infection in patients with B-cell non-Hodgkin…”
Get full text

A novel Bcl-2 Bcl-X Bcl-w inhibitor ABT-737 as therapy in multiple myeloma by Chauhan, D, Velankar, M, Brahmandam, M, Hideshima, T, Podar, K, Richardson, P, Schlossman, R, Ghobrial, I, Raje, N, Munshi, N, Anderson, K C

“…Bcl-2 or Bcl-X(L) confers resistance to chemotherapy in multiple myeloma (MM). Here we characterized the effects of ABT-737, a potent small-molecule inhibitor…”
Get full text

A novel Bcl-2/Bcl-X sub(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma by Chauhan, D, Velankar, M, Brahmandam, M, Hideshima, T, Podar, K, Richardson, P, Schlossman, R, Ghobrial, I, Raje, N, Munshi, N, Anderson, K C

“…Bcl-2 or Bcl-X sub(L) confers resistance to chemotherapy in multiple myeloma (MM). Here we characterized the effects of ABT-737, a potent small-molecule…”
Get full text

An update on high grade B-cell lymphoma by Velankar, Milind M., Sydney Sir Philip, John Kennedy, Venkataraman, Girish

Get full text

A novel Bcl-2/Bcl-X sub(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma by Chauhan, D, Velankar, M, Brahmandam, M, Hideshima, T, Podar, K, Richardson, P, Schlossman, R, Ghobrial, I, Raje, N, Munshi, N, Anderson, K C

“…Bcl-2 or Bcl-X sub(L) confers resistance to chemotherapy in multiple myeloma (MM). Here we characterized the effects of ABT-737, a potent small-molecule…”
Get full text

Transdifferentiation of high-grade B-cell lymphoma with MYC and BCL2 rearrangements into histiocytic sarcoma after CAR T-cell therapy: a case report by Gauto-Mariotti, Estefania, Nguyen, Amanda J., Waters, Chloe, Scurti, Gina M., Haddad, Sandra, Velankar, Milind M., Dalheim, Annika V., Dronzek, Victoria, Ketterling, Rhett P., Nishimura, Michael I., Dalland, Joanna C., Hossain, Nasheed M.

“…Histiocytic sarcoma/malignant histiocytosis is a rare, aggressive neoplasm that can occur as a primary malignancy or secondary to another hematologic neoplasm…”
Get full text

Passive Sonar Array Sub-space Processing based on Modal Decomposition by Zurk, L.M., Velankar, M.

“…In passive underwater sonar, current attention is on large arrays which can provide the needed array gain and high resolution beamforming. However, full-rank…”
Get full text

CARDIAC ARREST FOLLOWING CENTRAL VENOUS CANNULATION by VELANKAR, PM

Get full text

PERIPARTUM CARDIOMYOPATHY AND ANAESTHESIA: Author's Reply by VELANKAR, PM

Get full text